Serum metabolomic profiles suggest influence of sex and oral contraceptive use

American Journal of Translational Research

Volumn 6, Issue 5, 2014, Pages 614-624

  Ruoppolo, Margherita ^a,b   Campesi, Ilaria ^c,d   Scolamiero, Emanuela ^b   Pecce, Rita ^a   Caterino, Marianna ^e   Cherchi, Sara ^f   Mercuro, Giuseppe ^g   Tonolo, Giancarlo ^f   Franconi, Flavia ^c,d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^c UNIVERSITY OF SASSARI   (Italy)

^d NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

^e IRCCS SDN   (Italy)

^f San Giovanni di Dio Hospital   (Italy)

^g UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Acylcarnitines; Amino acids; Carnitine; Metabolomics; Oral contraceptives; Sex

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARAGINE; ASPARTATE AMINOTRANSFERASE; CITRULLINE; ETHINYLESTRADIOL; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; GESTAGEN; GLUTAMIC ACID; GLUTAMINE; GLYCINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HISTIDINE; HYDROXYPROLINE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; ORNITHINE; PROLINE; TRIACYLGLYCEROL; TYROSINE; VALINE;

ADULT; AMINO ACID ANALYSIS; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; BODY MASS; CHEMICAL ANALYSIS; ERYTHROCYTE COUNT; FEMALE; HEMATOCRIT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERGLYCEMIA; IRON METABOLISM; MALE; MASS SPECTROMETRY; METABOLOMICS; NORMAL HUMAN; ORAL CONTRACEPTIVE USE; SEX DIFFERENCE;

EID: 84908068717     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Legato MJ. Principles of Gender-Specific Amsterdam, Boston: Elsevier Academic Press; 2009.
2. Franconi F, Carru C, Spoletini I, Malorni W, Vella S, Mercuro G, Deidda M and Rosano G. A GENS-based approach to cardiovascular pharmacology: impact on metabolism, pharmacokinetics and pharmacodynamics. Ther Deliv 2011; 2: 1437-1453.
3. Mittelstrass K, Ried JS, Yu Z, Krumsiek J, Gieger C, Prehn C, Roemisch-Margl W, Polo-nikov A, Peters A, Theis FJ, Meitinger T, Kro-nenberg F, Weidinger S, Wichmann HE, Suhre K, Wang-Sattler R, Adamski J and Illig T. Discovery of sexual dimorphisms in metabolic and genetic biomarkers. PLoS Genet 2011; 7: e1002215.
4. Sewell AC and Bohles HJ. Acylcarnitines in intermediary metabolism. Eur J Pediatr 1995; 154: 871-877.
5. Steiber A, Kerner J and Hoppel CL. Carnitine: a nutritional, biosynthetic, and functional perspective. Mol Aspects Med 2004; 25: 455-473.
6. Slupsky CM, Rankin KN, Wagner J, Fu H, Chang D, Weljie AM, Saude EJ, Lix B, Adamko DJ, Shah S, Greiner R, Sykes BD and Marrie TJ. Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Anal Chem 2007; 79: 6995-7004.
7. Reuter SE, Evans AM, Chace DH and Fornasini G. Determination of the reference range of endogenous plasma carnitines in healthy adults. Ann Clin Biochem 2008; 45: 585-592.
8. Vaz FM and Wanders RJ. Carnitine biosynthesis in mammals. Biochem J 2002; 361: 417-429.
9. Vaz FM, Ofman R, Westinga K, Back JW and Wanders RJ. Molecular and biochemical characterization of rat epsilon -N-trimethyllysine hydroxylase, the first enzyme of carnitine biosynthesis. J Biol Chem 2001; 276: 33512-33517.
10. Lindstedt G and Lindstedt S. Cofactor requirements of gamma-butyrobetaine hydroxylase from rat liver. J Biol Chem 1970; 245: 4178-4186.
11. Fenkci SM, Fenkci V, Oztekin O, Rota S and Karagenc N. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome. Hum Reprod 2008; 23: 1602-1606.
12. Cederblad G, Fahraeus L and Lindgren K. Plasma carnitine and renal-carnitine clearance during pregnancy. Am J Clin Nutr 1986; 44: 379-383.
13. Keller U, van der Wal C, Seliger G, Scheler C, Ropke F and Eder K. Carnitine status of pregnant women: effect of carnitine supplementation and correlation between iron status and plasma carnitine concentration. Eur J Clin Nutr 2009; 63: 1098-1105.
14. Ringseis R, Hanisch N, Seliger G and Eder K. Low availability of carnitine precursors as a possible reason for the diminished plasma carnitine concentrations in pregnant women. BMC Pregnancy Childbirth 2010; 10: 17.
15. Armstrong MD and Stave U. A study of plasma free amino acid levels. II. Normal values for children and adults. Metabolism 1973; 22: 561-569.
16. Caballero B, Gleason RE and Wurtman RJ. Plasma amino acid concentrations in healthy elderly men and women. Am J Clin Nutr 1991; 53: 1249-1252.
17. Moller SE. Effect of oral contraceptives on tryptophan and tyrosine availability: evidence for a possible contribution to mental depression. Neuropsychobiology 1981; 7: 192-200.
18. Moller SE, Maach-Moller B, Olesen M, Madsen B, Madsen P and Fjalland B. Tyrosine metabolism in users of oral contraceptives. Life Sci 1995; 56: 687-695.
19. Campesi I, Sanna M, Zinellu A, Carru C, Rubattu L, Bulzomi P, Seghieri G, Tonolo G, Palermo M, Rosano G, Marino M and Franconi F. Oral contraceptives modify DNA methylation and monocyte-derived macrophage function. Biol Sex Differ 2012; 3: 4.
20. Rose DP, Leklem JE, Brown RR and Potera C. Effect of oral contraceptives and vitamin B6 supplements on alanine and glycine metabolism. Am J Clin Nutr 1976; 29: 956-960.
21. Estrogens and Progestins. In: Brunton L, Chabner B, Knollmann B, editors. Goodman & Gilman’s The Pharmacological Basis of The-rapeutics. pp. 12. manca l’anno.
22. Cain J, Lowell J, Thorndyke L and Localio AR. Contraceptive requirements for clinical research. Obstet Gynecol 2000; 95: 861-866.
23. Millington DS, Kodo N, Norwood DL and Roe CR. Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis 1990; 13: 321-324.
24. Millington D, Kodo N, Terada N, Roe D and Chase D. The analysis of diagnostic markers of genetic disorders to human blood and urine using tandem mass spectrometry with liquid secondary ion mass spectrometry. Int J Mass Spectrom Ion Proc 1991; 111: 211-228.
25. Whitley R, Hannon W, Dietzen D and Rinaldo P. Pre-analytical, analytical, and post-analytical issues related to follow-up testing of positive newborn screens. In: Bennett M, editors. Laboratory Medicine Practice Guidelines. Follow-up Testing for Metabolic Diseases Identified by Expanded Newborn Screening Using Tandem Mass Spectrometry. Washing-ton, DC; 2009. pp. 9-29.
26. Turnell DC and Cooper JD. Rapid assay for amino acids in serum or urine by pre-column derivatization and reversed-phase liquid chromatography. Clin Chem 1982; 28: 527-531.
27. Schuster R. Determination of amino acids in biological, pharmaceutical, plant and food samples by automated precolumn derivatization and high-performance liquid chromatography. J Chromatogr 1988; 431: 271-284.
28. Parvy PR, Bardet JI, Rabier DM, Saudubray JM and Kamoun PP. Ion-exchange chromatography and clinical criteria in the screening of the aminoacidopathies. Clin Chim Acta 1988; 176: 269-277.
29. Fowler B, Burlina A, Kozich V and Vianey-Saban C. Quality of analytical performance in inherited metabolic disorders: the role of ERNDIM. J Inherit Metab Dis 2008; 31: 680-689.
30. Nishijima S, Sugaya K, Fukuda T, Miyazato M, Ashimine S and Ogawa Y. Serum amino acids as indicators of cerebrospinal neuronal activity in patients with micturition disorders. Int J Urol 2006; 13: 1479-1483.
31. Zlotnik A, Gruenbaum BF, Mohar B, Kuts R, Gruenbaum SE, Ohayon S, Boyko M, Klin Y, Sheiner E, Shaked G, Shapira Y and Teichberg VI. The effects of estrogen and progesterone on blood glutamate levels: evidence from changes of blood glutamate levels during the menstrual cycle in women. Biol Reprod 2011; 84: 581-586.
32. Pitkanen HT, Oja SS, Kemppainen K, Seppa JM and Mero AA. Serum amino acid concentrations in aging men and women. Amino Acids 2003; 24: 413-421.
33. Bancel E, Strubel D, Bellet H, Polge A, Peray P and Magnan de Bornier B. Effect of the age and the sex on plasma concentration of amino acids. Ann Biol Clin (Paris) 1994; 52: 667-670.
34. Proenza AM, Crespi C, Roca P and Palou A. Gender related differences in the effect of aging on blood amino acid compartmentation. J Nutr Biochem 2001; 12: 431-440.
35. Moller SE, Moller BM, Olesen M and Fjalland B. Effects of oral contraceptives on plasma neutral amino acids and cholesterol during a menstrual cycle. Eur J Clin Pharmacol 1996; 50: 179-184.
36. Tipton KD, Elliott TA, Ferrando AA, Aarsland AA and Wolfe RR. Stimulation of muscle anabolism by resistance exercise and ingestion of leucine plus protein. Appl Physiol Nutr Metab 2009; 34: 151-161.
37. Lamont LS, McCullough AJ and Kalhan SC. Gender differences in the regulation of amino acid metabolism. J Appl Physiol 2003; 95: 1259-1265.
38. Nishizawa S, Benkelfat C, Young SN, Leyton M, Mzengeza S, de Montigny C, Blier P and Diksic M. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci U S A 1997; 94: 5308-5313.
39. Cederblad G. Plasma carnitine and body composition. Clin Chim Acta 1976; 67: 207-212.
40. Borum PR. Plasma carnitine compartment and red blood cell carnitine compartment of healthy adults. Am J Clin Nutr 1987; 46: 437-441.
41. Takiyama N and Matsumoto K. Age-and sex-related differences of serum carnitine in a Japanese population. J Am Coll Nutr 1998; 17: 71-74.
42. Amatayakul K, Laokuldilok T, Koottathep S, Dejsarai W, Prapamontol T, Srirak N, Tansuhaj A and Uttaravichai C. The effect of oral contraceptives on protein metabolism. J Med Assoc Thai 1994; 77: 509-516.
43. Campesi I, Carru C, Zinellu A, Occhioni S, Sanna M, Palermo M, Tonolo G, Mercuro G and Franconi F. Regular cigarette smoking influences the transsulfuration pathway, endothelial function, and inflammation biomarkers in a sex-gender specific manner in healthy young humans. Am J Transl Res 2013; 5: 497-509.
44. Gacias M, Perez-Marti A, Pujol-Vidal M, Marrero PF, Haro D and Relat J. PGC-1beta regulates mouse carnitine-acylcarnitine translocase through estrogen-related receptor alpha. Biochem Biophys Res Commun 2012; 423: 838-843.
45. Lango R, Smolenski RT, Narkiewicz M, Suchorzewska J and Lysiak-Szydlowska W. Influence of L-carnitine and its derivatives on myocardial metabolism and function in ischemic heart disease and during cardiopulmonary bypass. Cardiovasc Res 2001; 51: 21-29.
46. Magoulas PL and El-Hattab AW. Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management. Orphanet J Rare Dis 2012; 7: 68.
47. Flanagan JL, Simmons PA, Vehige J, Willcox MD and Garrett Q. Role of carnitine in disease. Nutr Metab (Lond) 2010; 7: 30.
48. Tamai I. Pharmacological and pathophysiological roles of carnitine/organic cation transporters (OCTNs: SLC22A4, SLC22A5 and Slc22-a21). Biopharm Drug Dispos 2013; 34: 29-44.
49. Lerner A, Gruener N and Iancu TC. Serum carnitine concentrations in coeliac disease. Gut 1993; 34: 933-935.
50. Khan HA, Alhomida AS, Madani HA and Sobki SH. Carnitine and acylcarnitine profiles in dried blood spots of patients with acute myocardial infarction. Metabolomics 2013; 9: 828-838.
51. Ford DA, Han X, Horner CC and Gross RW. Accumulation of unsaturated acylcarnitine molecular species during acute myocardial ischemia: metabolic compartmentalization of products of fatty acyl chain elongation in the acylcarnitine pool. Biochemistry 1996; 35: 7903-7909.
52. Regitz V, Shug AL and Fleck E. Defective myocardial carnitine metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary, hypertensive and valvular heart diseases. Am J Cardiol 1990; 65: 755-760.
53. Ino T, Sherwood WG, Benson LN, Wilson GJ, Freedom RM and Rowe RD. Cardiac manifestations in disorders of fat and carnitine metabolism in infancy. J Am Coll Cardiol 1988; 11: 1301-1308.
54. Guyton A. Textbook of Medical Physiology. Philadelphia: Saunders; 1986.
55. Rademaker M. Do women have more adverse drug reactions? Am J Clin Dermatol 2001; 2: 349-351.